Actively Recruiting
Transcranial Magnetic Stimulation Treatment for Veterans with Moderate to Severe PTSD A Pilot Study to Explore Brain and Inflammation Effects
Led by White River Junction Veterans Affairs Medical Center · Updated on 2026-06-15
20
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying how repetitive Transcranial Magnetic Stimulation rTMS may improve symptoms of posttraumatic stress disorder PTSD in veterans. The study aims to understand the effects of rTMS on brain activity and systemic inflammation related to PTSD by evaluating changes in the limbic system and inflammatory markers. This pilot study involves adults aged 19 to 70 who have moderate to severe PTSD and are eligible for VA healthcare. Participants receive ten 40-minute sessions of low frequency rTMS 1Hz targeting the right dorsolateral prefrontal cortex over 2 to 4 weeks. During the study, participants undergo functional MRI fMRI scans to observe brain activity changes and provide breath and blood samples to assess inflammation. This open-label trial evaluates the effect of rTMS without a comparison group. Throughout the study, participants are assessed for PTSD symptom frequency and intensity using the CAPS-5 and PCL-5 questionnaires from enrollment to three months after treatment. Depression symptoms are also measured using a self-reported inventory. Participants provide consent, undergo motor threshold testing, and are monitored for safety. The total study duration includes treatment and follow-up assessments lasting up to three months.
CONDITIONS
Brief Title
Transcranial Magnetic Stimulation in Veterans With PTSD
Research Team
B
Bradley V Watts, MD, MPH
J
Julian Sewall
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here